Please login to the form below
Mallinckrodt
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Mallinckrodt's Japan sales performance.
Mallinckrodt reaches tentative $1.6bn opioid settlement
Mallinckrodt’s speciality US generics business – which includes its opioid drug franchise – will file for chapter 11 bankruptcy protection as part of the wide-scale agreement. ... Last September, Mallinckrodt sold off its contract development and
J&J proposes $4bn in cash to settle opioid crisis allegations
Mallinckrodt also agreed to pay $30m to settle allegations from two Ohio counties that it helped fuel the epidemic in September, with $24m in cash to be paid, and $6m donated
Insys gets bankruptcy court okay for Subsys sale
crisis, while Mallinckrodt has also been reported to be at risk as it tries to pursue its own settlement deals.
Mallinckrodt offloads CDMO for $250m
Mallinckrodt is also facing mounting blame for its part in the opioid epidemic in the US. ... Following the announcement of Mallinckrodt's CDMO sale, shares jumped in pre-market trading to 13%.
Humana lawsuit targets Mallinckrodt's 'billion-dollar golden goose'
Secondly, Humana alleges Mallinckrodt artificially inflated demand “by using a charitable foundation for the illegal purpose of paying patient co-pays”. ... The nonprofit allegedly used money from Mallinckrodt to provide patient assistance funds
1 2 3 4 5 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Featured jobs
-
Account Director
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
-
Account director
-
Competitive salary and bonus scheme
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
- Account Director, Healthcare Communications
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
-
Account Manager
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Publications director
-
Competitive salary and bonus scheme
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Account Manager (PR)
-
Great Benefits
Subscribe to our email news alerts
- Immutep spikes on trial of its LAG-3 drug with Keytruda
- US backs Sanofi’s ‘fast-track’ coronavirus vaccine
- As new coronavirus outbreaks emerge, fears of a global pandemic escalate
- Coronavirus outbreak escalation could impact drug supply chain
- FDA accepts review to broaden GSK’s Zejula label
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Celgene’s Revlimid scores NICE approval in follicular lymphoma
- Menlo slumps as itching drug fails mid-stage trial
- Trial of Amgen, Servier’s heart failure drug clears interim check
- Policy and public health: all the decisions we can't see
- Genentech pays $30m upfront to access Bicycle Therapeutic's discovery technology
- The ALS patient journey
PMHub
Market Access Transformation
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...
Latest intelligence
- The ALS patient journey
- Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
- Equipping your medical affairs teams with solutions to navigate the healthcare landscape
- Dr Tyler Ray, OPEN Health Medical Communications...
- Can protein degraders unlock ‘undruggable’ drug targets?
- Exploring a new and exciting area of small-molecule drug discovery...
Quick links
Infographics
